Friday, 27 December 2024
  
Login

Australia's most trusted
source of pharma news

Friday, 27 December 2024
News

Private scripts for opioids soar

Posted 11 December 2024 AM

While there has been a 33 per cent reduction in PBS dispensing claims for opioid analgesics as part of a Federal Government push to curb use of the drugs, about a quarter of the drop was offset by a 55 per cent jump in private scripts for the medicines.

New research published in the International Journal of Drug Policy found Australia's use of prescription opioid analgesics, such as oxycodone, morphine, or tramadol, dropped by 21 per cent between 2015 and 2022, however, these statistics do not capture private scripts or medicines supplied to public hospital inpatients.

To see the whole article, please login


Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.